Kintor Pharma Announces First Patient Dosing in Phase III Clinical Trial of Proxalutamide for the Treatment of Hospitalized COVID-19 Patients in US

Kintor Pharma Announces First Patient Dosing In Phase Iii Clinical Trial Of Proxalutamide For The Treatment Of Hospitalized Covid 19 Patients In Us

Facebook Comments

Leave a Reply

CommentLuv badge